, /PRNewswire/ --Â Western Midstream Partners, LP (NYSE: WES) ("WES") and Aris Water Solutions, Inc. (NYSE: ARIS) ("Aris") jointly announced today the preliminary results of the elections made by Aris securityholders regarding the form of merger consideration (the "Merger Consideration") to be received in connection with WES's pending acquisition of Aris (the "Transaction"). As further described in (i) the Agreement and Plan of Merger, dated as of August 6, 2025, by and among WES, Aris and the other parties ...

Fort Worth, TX, Oct. 07, 2025 (GLOBE NEWSWIRE) -- EQV Ventures Acquisition Corp. (NYSE: EQV) (“EQV”), a special purpose acquisition company sponsored by EQV Group, and Presidio Investment Holdings, LLC (“PIH”), a differentiated oil and gas operator focused on the optimization of mature, producing oil and natural gas assets in the United States, today announced the filing of an amendment to the registration statement on Form S-4 (as amended, the “Registration Statement”) with the U.S. Securities and Exchange ...

Company Overview - SACH Pte. Ltd. is engaged in the gaming, technology, e-commerce, retail, and live events industries, headquartered in Singapore [3][10] - The company's main objective is to integrate digital and physical experiences through innovative platforms, enhancing community engagement and consumer interaction [3][10] - SACH is known for its social technology platform, OMMiii, which incorporates gamification and data analytics to facilitate engagement strategies for brands and events [3][10] Proposed Transaction - SACH has entered into a merger agreement with Quantumsphere Acquisition Corporation, which will result in SACH becoming a wholly-owned subsidiary of Omnivate Global Ltd. [2][5] - The combined company is expected to have an implied initial pro forma equity value of approximately $300 million, assuming no redemptions [6][8] - The transaction is anticipated to provide SACH with cash proceeds of up to approximately $82.8 million to fund its business operations, assuming no redemptions and excluding transaction fees [6][8] Leadership Statements - Jonathan Zhang, CEO of SACH, stated that the merger is a transformative milestone that will help redefine engagement with digital and physical experiences [4] - Ping Zhang, Chairman/CEO of Quantumsphere, emphasized the commitment to pairing their public market platform with an operator capable of executing growth strategies [4] Financial Advisors - Geneva Capital Group serves as the financial advisor to SACH, while Celine & Partners, PLLC and KPMG Law Firm provide legal advisory services to Quantumsphere and SACH, respectively [9]

Core Viewpoint - Western Midstream Partners, LP (WES) is set to acquire Aris Water Solutions, Inc. (Aris), with the election deadline for Aris securityholders to choose their merger consideration established for October 7, 2025, and the transaction expected to close on October 15, 2025, pending stockholder approval and customary closing conditions [2][5]. Group 1: Transaction Details - The merger consideration options for Aris securityholders include: (i) 0.625 WES common units, (ii) a combination of $7.00 in cash and 0.450 WES common units, or (iii) $25.00 in cash, with the total cash consideration capped at $415.0 million [5][6]. - Aris securityholders who do not submit a completed election form by the deadline will automatically be deemed to have chosen the common unit election consideration [6]. - The expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act on September 26, 2025, is a significant milestone for the transaction [9]. Group 2: Company Profiles - Western Midstream Partners, LP is a master limited partnership focused on developing, acquiring, owning, and operating midstream assets across several states, including Texas and New Mexico, with a business model that minimizes exposure to commodity price volatility through fee-based contracts [10]. - Aris Water Solutions, Inc. specializes in environmental infrastructure and solutions, providing full-cycle water handling and recycling services aimed at enhancing sustainability for energy companies, particularly in the Permian Basin [12].

Article contentPursuant to the Voting Agreement, and subject to its terms and conditions, Halcyon has agreed to vote its Artis Units in favour of the Transaction. Under the Voting Agreement, Halcyon is also restricted from tendering or voting its Artis Units in support of any alternative acquisition proposal relating to Artis. Furthermore, Halcyon is required to vote against any competing proposals or actions that could reasonably be expected to prevent, delay, or frustrate the completion of the Transaction ...

Group 1 - Relativity Acquisition Corp. announced a proposed business combination with Instinct Brothers Co., Ltd., a vertically integrated stem cell skincare and wellness company based in Tokyo, Japan [1][2] - Instinct Brothers specializes in stem cell skincare and wellness products, focusing on research and development, manufacturing, distribution, retail, and clinical applications since its founding in 2011 [2] - The combined entity will operate under the name Instinct Bio Technical Company Holdings Inc. and plans to list on the NASDAQ Stock Exchange with the ticker symbol 'BIOT' [1] Group 2 - The registration statement on Form F-4 has been filed with the SEC, which includes a preliminary proxy statement/prospectus detailing the business combination and related shareholder vote [1][4] - The business combination aims to advance stem cell science and enhance patient outcomes, aligning with Instinct Brothers' mission to innovate in regenerative medicine [2] - Relativity Acquisition Corp. is a blank check company formed to effect mergers and similar business combinations [3]

Core Viewpoint - Blue Water Acquisition Corp. III has submitted a $10 billion bid to acquire PDV Holding Inc., the parent company of Citgo Petroleum Corp., in a court-supervised auction process in Delaware [1][2]. Group 1: Acquisition Proposal - The proposal includes cash or stock distributions to PDV Holding Inc.'s general creditors and a $3.2 billion settlement for holders of the PDVSA 2020 bonds, which can be paid in cash or shares of the new publicly listed entity that will own Citgo [2]. - The acquisition aims to return Citgo to U.S. ownership as a fully public company, ensuring accountability to U.S. regulators and investors [3]. Group 2: Management Commentary - Joseph Hernandez, Chairman & CEO of Blue Water, stated that the $10 billion proposal is designed to provide creditors with immediate recovery and the opportunity to participate in Citgo's future as a U.S. public company [4]. - The structure of the proposal aims to deliver value for creditors, stability for employees, and maintain Citgo's assets under U.S. ownership and public market transparency [4]. Group 3: Citgo Assets - The auction includes significant assets such as three major U.S. refineries located in Lake Charles, Louisiana; Lemont, Illinois; and Corpus Christi, Texas, with a combined refining capacity exceeding 800,000 barrels per day [6]. - Additional assets include midstream infrastructure like pipelines and terminals, lubricant and blending plants, and a nationwide retail distribution network of over 4,000 branded service stations [6].

Company Overview - YD Biopharma Limited is a clinical-stage biopharmaceutical company focused on cancer prevention medical diagnostics and the development of exosome-based therapeutics aimed at addressing diseases with high unmet medical needs [6] - The company has established itself as a recognized supplier of clinical trial drugs and is also developing post-market auxiliary products [6] Business Combination Details - Breeze Holdings Acquisition Corp. announced the approval of its business combination with YD Biopharma, with stockholders voting overwhelmingly in favor (3,127,474 shares for, 1,000 against, and 21 abstentions) [3] - The combined entity will operate under the name YD Bio Limited and is expected to trade on Nasdaq with the ticker symbol "YDES" [4] - The transaction is anticipated to close within the next two weeks, pending customary closing conditions [4] Advisors Involved - Legal and financial advisors for the transaction include ArentFox Schiff LLP for YD Biopharma, I-Bankers Securities, Inc. for Breeze, and Woolery & Co. PLLC for Breeze [5]

Financial Performance - Arcadia Biosciences reported an 11% increase in total revenues for the second quarter of 2025, amounting to $1.455 million compared to $1.306 million in the same period of 2024 [3][5][7] - Zola® coconut water sales drove this revenue growth, with a 24% increase, contributing $280,000 to the total revenue in Q2 2025 [3][8] - For the first half of 2025, total revenues increased by 16% to $2.655 million, with Zola revenues rising by 47% [9] Operating Expenses - Total operating expenses for Q2 2025 were $1.956 million, a significant increase compared to the previous year, primarily due to higher costs associated with Zola coconut water [5][10] - Cost of revenues for Zola increased by 30% in Q2 2025, reflecting a $191,000 rise [10] - SG&A expenses decreased by $560,000 in Q2 2025 compared to the same period in 2024, indicating improved operational efficiency [12] Net Income and Loss - The net loss attributable to common stockholders for Q2 2025 was $4.458 million, a significant decline from a net income of $1.061 million in Q2 2024, largely due to a $4.5 million credit loss related to a note receivable [17][19] - For the first half of 2025, the net loss attributable to common stockholders was $1.9 million, compared to a loss of $1.4 million in the same period of 2024 [19] Strategic Developments - Arcadia received 2.7 million shares of stock in Above Food Ingredients Inc. as part of a repayment related to the sale of GoodWheat™ assets [4][15] - The company has eliminated $1 million in contingent liabilities, contributing to a total of $2 million in liabilities removed year-to-date [4] Business Combination - The pending business combination with Roosevelt Resources is progressing, with an amendment filed to the initial Form S-4 registration statement to address SEC comments and provide updated financial information [5][20]

Core Viewpoint - Cascadia Minerals Ltd. has successfully acquired Granite Creek Copper Ltd. through a court-approved plan of arrangement, creating a leading Yukon copper-gold exploration and development company [1][2]. Company Overview - The merger allows Cascadia to enhance its property portfolio, which includes the advanced-stage Carmacks Property and various discovery-stage projects in Yukon's Stikine Terrane [2]. - The Carmacks Project hosts a Measured and Indicated Resource of 651 million pounds of copper and 302 thousand ounces of gold, with a 2023 Preliminary Economic Assessment (PEA) indicating a post-tax NPV of $230.5 million and a post-tax IRR of 29% [8][12]. Shareholder Exchange - Each Granite Creek shareholder received 0.25 Cascadia common shares for each Granite Creek share held, resulting in the issuance of 53,070,848 Cascadia shares [2]. - The transaction also involved the exchange of Granite Creek's stock options for 3,747,500 Cascadia stock options and adjustments to warrants allowing holders to acquire 11,036,291 Cascadia shares [2]. Board of Directors Changes - Timothy Johnston, former President and CEO of Granite Creek, has joined Cascadia's board, while James Sabala and Kurt Allen have resigned from Cascadia's board [3]. Financing Details - Cascadia completed a private placement, converting 14,459,894 subscription receipts into shares and warrants, raising gross proceeds of C$2,024,385 [4]. - Finders' fees totaling $82,223 were paid, along with the issuance of 587,308 finder warrants to various finders [5]. Additional Information - Further details regarding the arrangement can be found in the news releases and management information circulars filed on SEDAR+ [6].